Table 1.
miRNAs regulate the expression of YAP/TAZ and cancer progression
| MiRNAs | Cancer type | Role in cancer | Targets | Functions | Reference |
|---|---|---|---|---|---|
| miR-599 | bladder urothelial carcinoma | tumor suppressor | YAP1 | inhibit proliferation, invasion, promote apoptosis | [46] |
| miR-15a-5p | cervical cancer | tumor suppressor | YAP1 | inhibit viability, migration and invasion, induce apoptosis | [47] |
| miR-591 | breast cancer | tumor suppressor | YAP1 | inhibit proliferation and invasion | [48] |
| miR-1285-3p | osteosarcoma | tumor suppressor | YAP1 | inhibit proliferation and invasion | [49] |
| miR-345 | non-small cell lung cancer | tumor suppressor | YAP1 | inhibit migration and invasion | [50] |
| miR-424-3p | non-small cell lung cancer | tumor suppressor | YAP1 | inhibit proliferation,migration and invasion,enhance chemoresistance | [51] |
| miR-27a-3p | oral squamous cell carcinoma | tumor suppressor | YAP1 | inhibit EMT process | [52] |
| miR-26b | non-small cell lung cancer | tumor suppressor | TAZ | suppress the cisplatin resistance | [53] |
| miR-92a-3p | cervical cancer | oncogene | LAST1 | promote proliferation,invasion and cell cycle transition | [54] |
| miR-92 | ovarian cancer | oncogene | LATS2 | promote proliferation and migration, induce immune suppression | [55] |
| miRNA-224-3p | retinoblastoma | oncogene | LATS2 | promote proliferation and angiogenesis,inhibit apoposis | [56] |
| miR-31 | esophageal squamous cell carcinoma | oncogene | LATS2 | promote proliferation, migration, invasion and EMT process, induce apoptosis | [57] |
| miR-520b | breast cancer | oncogene | LATS2 | promote migration, EMT process and cancer cell stemness | [58] |
| miR-216a-3p | cervical cancer | tumor suppressor | ACTL6A | inhibit proliferation,migration | [59] |